JP5505577B1 - Pectin aqueous solution - Google Patents

Pectin aqueous solution Download PDF

Info

Publication number
JP5505577B1
JP5505577B1 JP2013553705A JP2013553705A JP5505577B1 JP 5505577 B1 JP5505577 B1 JP 5505577B1 JP 2013553705 A JP2013553705 A JP 2013553705A JP 2013553705 A JP2013553705 A JP 2013553705A JP 5505577 B1 JP5505577 B1 JP 5505577B1
Authority
JP
Japan
Prior art keywords
pectin
aqueous
solution
aqueous solution
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2013553705A
Other languages
Japanese (ja)
Other versions
JPWO2014010577A1 (en
Inventor
浩平 山下
学 長野
博 西山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QP Corp
Original Assignee
QP Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QP Corp filed Critical QP Corp
Priority to JP2013553705A priority Critical patent/JP5505577B1/en
Application granted granted Critical
Publication of JP5505577B1 publication Critical patent/JP5505577B1/en
Publication of JPWO2014010577A1 publication Critical patent/JPWO2014010577A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/231Pectin; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

ナトリウム含有量が180mg/100mL以上の経腸栄養剤であっても増粘させることができ、保存中に澱が発生しないペクチン水溶液を提供する。このペクチン水溶液は、エステル化度5〜15%、粘度平均分子量が10000〜35000のペクチンを含有する。ペクチン水溶液のカルシウム濃度は9ppm以下、ペクチン水溶液の粘度(25℃)は1〜30mPa・sである。ペクチン水溶液100mLと、塩化カルシウム0.019mol/L、クエン酸ナトリウム0.020mol/Lのカルシウム・ナトリウム水溶液200mLとの混合液の粘度(25℃)が700〜10000mPa・sである。
Provided is an aqueous pectin solution that can be thickened even with an enteral nutrient having a sodium content of 180 mg / 100 mL or more and does not generate starch during storage. This aqueous pectin solution contains pectin having an esterification degree of 5 to 15% and a viscosity average molecular weight of 10,000 to 35,000. The calcium concentration of the aqueous pectin solution is 9 ppm or less, and the viscosity (25 ° C.) of the aqueous pectin solution is 1 to 30 mPa · s. The viscosity (at 25 ° C.) of a mixture of 100 mL of an aqueous pectin solution and 200 mL of an aqueous calcium / sodium solution of 0.019 mol / L calcium chloride and 0.020 mol / L sodium citrate is 700 to 10,000 mPa · s.

Description

本発明は、経腸栄養剤の増粘剤として有用なペクチン水溶液に関する。   The present invention relates to an aqueous pectin solution useful as a thickener for enteral nutrients.

食物や飲料を経口摂取することが不可能な者あるいは困難な者に栄養を補給するため、経管栄養法が行われている。経管栄養法には、鼻から胃へチューブを通して経腸栄養剤を投与する経鼻胃管法と、腹部に瘻孔を形成し、PEGチューブを用いて経腸栄養剤を投与する胃瘻があり、いずれの場合も経腸栄養剤は経管投与が可能な粘度の液体であることから、胃内に投与された経腸栄養剤が食道へ逆流して嘔吐を引き起こしたり、腸へ急速に流入して下痢やダンピング症候群を引き起こしたりすることが問題となる。特に、経鼻胃管法では細いチューブを通るように経腸栄養剤が低粘度に調整されるため、食道への逆流、下痢、ダンピング症候群が問題となる。   The tube feeding method is performed in order to supply nutrition to those who cannot or cannot take food and beverages orally. There are two types of tube feeding methods: the nasogastric tube method in which enteral nutrient is administered through the tube from the nose to the stomach, and the gastrostomy in which the fistula is formed in the abdomen and the enteral nutrient is administered using a PEG tube. In both cases, enteral nutrients are liquids with viscosity that can be administered by tube, so enteral nutrients administered into the stomach may flow back into the esophagus and cause vomiting or rapidly enter the intestines. It causes problems such as causing diarrhea and damping syndrome. In particular, in the nasogastric tube method, the enteral nutrient is adjusted to have a low viscosity so that it passes through a thin tube, so that reflux into the esophagus, diarrhea, and dumping syndrome are problematic.

そこで、経腸栄養剤の逆流、下痢、ダンピング症候群を防止するため、胃内で経腸栄養剤を増粘させるローメトキシルペクチン水溶液等の増粘剤が使用されている(特許文献1、2)。ローメトキシルペクチンは、ペクチンを構成するガラクツロン酸のうちメチルエステル化したものの割合であるエステル化度(DE)が50%未満であり、カルシウムイオン等の2価の金属イオンの存在でゲルを形成する。   Therefore, in order to prevent reflux of enteral nutrients, diarrhea, and dumping syndrome, thickeners such as low methoxyl pectin aqueous solution that thicken enteral nutrients in the stomach are used (Patent Documents 1 and 2). . Low methoxyl pectin has a degree of esterification (DE), which is a ratio of methyl esterified galacturonic acid constituting pectin, of less than 50%, and forms a gel in the presence of divalent metal ions such as calcium ions. .

WO2000/013529号パンフレットWO2000 / 013529 pamphlet 特開2000−217544号公報JP 2000-217544 A

一方、従来、経腸栄養剤としては、ナトリウム含有量が150mg/100mL以下のものが多く使用されているが、経腸栄養剤の長期の投与に伴う低ナトリウム血症を予防するため、ナトリウム含有量をより多くした経腸栄養剤、特にナトリウム濃度が180mg/100mL以上の経腸栄養剤も使用されるようになっている。   On the other hand, as a conventional enteral nutrient, one having a sodium content of 150 mg / 100 mL or less is often used. However, in order to prevent hyponatremia associated with long-term administration of enteral nutrient, Enteral nutrients having a larger amount, particularly enteral nutrients having a sodium concentration of 180 mg / 100 mL or more are also used.

しかしながら、ナトリウム含有量の高い経腸栄養剤は、従前のローメトキシルペクチンでは増粘しないという問題がある。これに対してローメトキシルペクチンのエステル化度をより低減させることやローメトキシルペクチンの含有量を増やすことが考えられるが、ローメトキシルペクチンのエステル化度を低減させるとローメトキシルペクチン水溶液の保存中に澱が発生してしまう。一方、ローメトキシルペクチンの含有量を増やすと、ローメトキシルペクチン水溶液の粘度が高くなるため、経鼻胃管のような細いチューブを通す際に、シリンジを用いて注入する医療従事者の負担が増えることとなる。   However, enteral nutrients with a high sodium content have a problem that they do not thicken with conventional low methoxyl pectin. On the other hand, it may be possible to further reduce the degree of esterification of low methoxyl pectin or increase the content of low methoxyl pectin. Starch is generated. On the other hand, increasing the content of low methoxyl pectin increases the viscosity of the aqueous solution of low methoxyl pectin, which increases the burden on medical personnel who inject using a syringe when passing through a thin tube such as a nasogastric tube It will be.

そこで、本発明は、ナトリウム含有量が180mg/100mL以上と高濃度にナトリウムを含有する経腸栄養剤であっても増粘させることができ、細いチューブでの経管投与に適した粘度であり、保存中に澱が発生しないペクチン水溶液の提供を目的とする。   Therefore, the present invention can increase the viscosity even with enteral nutrients containing sodium at a high concentration of 180 mg / 100 mL or more, and is suitable for tube administration in a thin tube. An object of the present invention is to provide an aqueous pectin solution that does not generate starch during storage.

本発明は、ペクチン水溶液に使用するペクチンのエステル化度と分子量を特定の範囲とし、かつペクチン水溶液に含まれるカルシウム濃度を特定の範囲以下にすると、上述の目的を達成できることを見出し、本発明を完成させた。   The present invention has found that the above-mentioned object can be achieved when the degree of esterification and molecular weight of pectin used in a pectin aqueous solution are within a specific range and the calcium concentration contained in the pectin aqueous solution is below a specific range. Completed.

即ち、本発明は、エステル化度5〜15%、粘度平均分子量が10000〜35000のペクチンを含有するペクチン水溶液であって、ペクチン水溶液のカルシウム濃度が9ppm以下、ペクチン水溶液の粘度(25℃)が1〜30mPa・sであり、該ペクチン水溶液100mLと、塩化カルシウム0.019mol/L、クエン酸ナトリウム0.020mol/Lのカルシウム・ナトリウム水溶液200mLとの混合液の粘度(25℃)が700〜10000mPa・sとなるペクチン水溶液を提供する。   That is, the present invention relates to a pectin aqueous solution containing pectin having an esterification degree of 5 to 15% and a viscosity average molecular weight of 10,000 to 35000, wherein the calcium concentration of the pectin aqueous solution is 9 ppm or less, and the viscosity (25 ° C.) of the pectin aqueous solution is 1 to 30 mPa · s, and the viscosity (25 ° C.) of a mixture of 100 mL of the aqueous pectin solution and 200 mL of an aqueous calcium / sodium solution of 0.019 mol / L calcium chloride and 0.020 mol / L sodium citrate is 700 to 10,000 mPa Provide an aqueous pectin solution that becomes s.

また、本発明は、上述のペクチン水溶液からなる経管投与用増粘剤を提供する。   Moreover, this invention provides the thickener for tube administration which consists of the above-mentioned pectin aqueous solution.

さらに、本発明は、上述のペクチン水溶液の製造方法として、エステル化度5〜15%のペクチンであって、該ペクチンを水で希釈してペクチン含有量1〜5質量%のペクチン水溶液を調製した場合に、そのペクチン水溶液のカルシウム濃度が9ppm以下となるペクチンを水で希釈し、ペクチン水溶液の粘度(25℃)を1〜30mPa・sに調整する方法を提供する。   Furthermore, the present invention provides a pectin aqueous solution having a degree of esterification of 5 to 15%, diluted with water, and having a pectin content of 1 to 5% by mass as a method for producing the above-described aqueous pectin solution. In this case, there is provided a method of adjusting the viscosity (25 ° C.) of the aqueous pectin solution to 1 to 30 mPa · s by diluting the pectin in which the calcium concentration of the aqueous pectin solution is 9 ppm or less with water.

本発明のペクチン水溶液によれば、従来のナトリウム含有量150mg/100mL以下の経腸栄養剤だけでなく、ナトリウム含有量がより多い経腸栄養剤、特にナトリウム含有量180mg/100mL以上の経腸栄養剤でも増粘させることができ、胃内に投与された経腸栄養剤の逆流、下痢、ダンピング症候群を防止することができる。   According to the aqueous pectin solution of the present invention, not only conventional enteral nutrients with a sodium content of 150 mg / 100 mL or less, enteral nutrients with a higher sodium content, particularly enteral nutrition with a sodium content of 180 mg / 100 mL or more. The agent can also increase the viscosity, and prevent reflux of enteral nutrients administered into the stomach, diarrhea, and damping syndrome.

また、本発明のペクチン水溶液によれば、保存中に澱が生じにくいため、使用者は安心して使用することができる。   In addition, according to the aqueous pectin solution of the present invention, since starch is unlikely to occur during storage, the user can use it with peace of mind.

以下、本発明を詳細に説明する。
本発明のペクチン水溶液は、主成分としてエステル化度(DE)5〜15%のローメトキシルペクチンを含有する。本発明のペクチン水溶液によれば、ペクチンのエステル化度が15%以下と低くカルシウム反応性が高いことにより、粘度平均分子量が10000〜35000、好ましくは12000〜27000に調節することと相まって、ペクチン水溶液の粘度が30mPa・s以下と低いながらも、経腸栄養剤がナトリウム含有量180mg/100mL以上と高ナトリウム濃度の場合でも、また、ナトリウム含有量がそれより低い場合でも、経腸栄養剤をこのペクチン水溶液と混合することにより、その経腸栄養剤を増粘させ、胃内に投与した経腸栄養剤の逆流、下痢、ダンピング症候群を防止することができる。より具体的には、例えば、ナトリウムを180〜220mg/100mLの高濃度で含有する経腸栄養剤100mLに対して本発明のペクチン水溶液を10〜100mL添加することにより、混合液の粘度(25℃)(BH型粘度計)を600〜10000mPa・s、好ましくは800〜3000mPa・sとすることができる。
Hereinafter, the present invention will be described in detail.
The aqueous pectin solution of the present invention contains low methoxyl pectin having an esterification degree (DE) of 5 to 15% as a main component. According to the aqueous pectin solution of the present invention, the degree of esterification of pectin is as low as 15% or less, and the calcium reactivity is high. Even if the enteral nutrient has a sodium content of 180 mg / 100 mL or more and a high sodium concentration, and the sodium content is lower than that, the enteral nutrient is By mixing with an aqueous pectin solution, the enteral nutrient can be thickened and reflux of enteral nutrients administered into the stomach, diarrhea, and dumping syndrome can be prevented. More specifically, for example, by adding 10 to 100 mL of the aqueous pectin solution of the present invention to 100 mL of enteral nutrient containing sodium at a high concentration of 180 to 220 mg / 100 mL, the viscosity of the mixed solution (25 ° C. ) (BH viscometer) can be 600 to 10000 mPa · s, preferably 800 to 3000 mPa · s.

一方、本発明のペクチン水溶液において、ペクチンのエステル化度は低すぎるとカルシウムイオンとの反応時に強固な不溶性のゲルとなり消化吸収の面から好ましくないため、5%以上とする。適度な粘度に増粘させる点から、ペクチン水溶液のエステル化度を5〜15%、より好ましくは6〜13%とする。エステル化度が15%よりも高すぎるとペクチン水溶液のカルシウムイオンとの反応性が低く、経腸栄養剤を十分に増粘させることができない。   On the other hand, in the aqueous pectin solution of the present invention, if the degree of esterification of pectin is too low, it becomes a strong insoluble gel upon reaction with calcium ions, which is not preferable from the viewpoint of digestion and absorption. From the point of increasing the viscosity to an appropriate viscosity, the degree of esterification of the aqueous pectin solution is 5 to 15%, more preferably 6 to 13%. If the degree of esterification is higher than 15%, the reactivity of the aqueous pectin solution with calcium ions is low, and the enteral nutrient cannot be thickened sufficiently.

なお、ペクチン水溶液のエステル化度は、アルカリ溶液による滴定法等で測定することができる。   The degree of esterification of the aqueous pectin solution can be measured by titration with an alkaline solution.

また、本発明のペクチン水溶液が主成分とするペクチンは、粘度平均分子量が10000〜35000、好ましくは12000〜27000である。ここで、粘度平均分子量は極限粘度法により算出される平均分子量である。ペクチンの粘度平均分子量が大きすぎるとカルシウムイオンとの反応により強固な不溶性のゲルが生成され、消化吸収の面から好ましくない。適度な粘度に増粘させる点から、ペクチン水溶液の粘度平均分子量を35000以下、好ましくは27000以下、より好ましくは16000以下とする。反対に、粘度平均分子量が小さすぎると、ペクチン水溶液のカルシウムイオンとの反応性が低く、経腸栄養剤を十分に増粘させることができないので、粘度平均分子量は10000以上、好ましくは12000以上、より好ましくは14000以上である。また、ペクチンの粘度平均分子量を上述の範囲とすることにより、ペクチン水溶液の粘度を、経管投与に適した30mPa・s(25℃)以下に調整することが容易となる。   Moreover, the pectin which the pectin aqueous solution of the present invention has as a main component has a viscosity average molecular weight of 10,000 to 35,000, preferably 12,000 to 27,000. Here, the viscosity average molecular weight is an average molecular weight calculated by an intrinsic viscosity method. If the viscosity average molecular weight of pectin is too large, a strong insoluble gel is generated by reaction with calcium ions, which is not preferable from the viewpoint of digestion and absorption. From the point of increasing the viscosity to an appropriate viscosity, the viscosity average molecular weight of the pectin aqueous solution is 35000 or less, preferably 27000 or less, more preferably 16000 or less. On the other hand, if the viscosity average molecular weight is too small, the reactivity with calcium ions in the aqueous pectin solution is low and the enteral nutrient cannot be sufficiently thickened. Therefore, the viscosity average molecular weight is 10,000 or more, preferably 12,000 or more. More preferably, it is 14000 or more. Moreover, by setting the viscosity average molecular weight of pectin within the above range, it becomes easy to adjust the viscosity of the aqueous pectin solution to 30 mPa · s (25 ° C.) or less suitable for tube administration.

本発明のペクチン水溶液が含有するペクチンは、上述のようにエステル化度5〜15%、粘度平均分子量が10000〜35000、好ましくは12000〜27000であることにより、このペクチン水溶液と経腸栄養剤とを混合した場合に、その混合液中のカルシウムイオン濃度が10ppm以上であると、ペクチン水溶液の粘度が、経管投与に適した30mPa・s(25℃)以下であっても混合液の粘度が600mPa・s以上に増粘する。経腸栄養剤のカルシウムイオン濃度は少なくとも10ppm以上であるから、本発明のペクチン水溶液により経腸栄養剤を増粘させることが可能となる。   As described above, the pectin contained in the aqueous pectin solution of the present invention has an esterification degree of 5 to 15% and a viscosity average molecular weight of 10,000 to 35,000, preferably 12,000 to 27,000. When the calcium ion concentration in the mixed solution is 10 ppm or more, the viscosity of the mixed solution is 30 mPa · s (25 ° C.) or less suitable for tube administration. Thicken to 600 mPa · s or more. Since the calcium ion concentration of the enteral nutrient is at least 10 ppm or more, the enteral nutrient can be thickened by the aqueous pectin solution of the present invention.

このような本発明のペクチン水溶液の増粘作用は、本発明のペクチン水溶液100mLと、塩化カルシウム0.019mol/L、クエン酸三ナトリウム0.020mol/Lのカルシウム・ナトリウム水溶液200mLとを30秒間撹拌し、ペクチン水溶液とカルシウム・ナトリウム水溶液とを混合してから5分後の粘度(25℃)をBH型粘度計で20rpm、液温25℃で測定した場合に、700〜10000mPa・s、好ましくは1400〜8000mPa・sとなることにより、従前のペクチン水溶液と区別される。なお、このカルシウム・ナトリウム水溶液におけるカルシウム含有量とナトリウム含有量は、汎用されている経腸栄養剤のカルシウム含有量とナトリウム含有量となっており、ペクチン水溶液を経腸栄養剤と混合した場合の増粘作用を調べるために使用される。従前のペクチン水溶液を、このカルシウム・ナトリウム水溶液と混合した場合には、上記粘度範囲とならない。   Such thickening action of the aqueous pectin solution of the present invention is achieved by stirring 100 mL of the aqueous pectin solution of the present invention and 200 mL of an aqueous calcium / sodium solution of 0.019 mol / L calcium chloride and 0.020 mol / L trisodium citrate for 30 seconds. When the viscosity (25 ° C.) 5 minutes after mixing the aqueous pectin solution and the aqueous calcium / sodium solution is measured at 20 rpm with a BH viscometer at a liquid temperature of 25 ° C., preferably 700 to 10,000 mPa · s, preferably By being 1400-8000 mPa * s, it distinguishes from the conventional pectin aqueous solution. In addition, the calcium content and sodium content in this calcium / sodium aqueous solution are the calcium content and sodium content of general enteral nutrients, and when pectin aqueous solution is mixed with enteral nutrients Used to examine thickening effect. When a conventional pectin aqueous solution is mixed with this calcium / sodium aqueous solution, the above viscosity range is not reached.

また、本発明のペクチン水溶液は、粘度(25℃)が30mPa・s以下、好ましくは10mPa・s以下である。ペクチン水溶液の粘度が高すぎると、経管投与で使用される内径1〜5mm程度のチューブを通してペクチン水溶液を投与することが困難となるが、ペクチン水溶液の粘度を上述の範囲とすることにより、ペクチン水溶液は経管投与に適したものとなり、特に、経鼻胃管法でも好ましく使用できるものとなる。なお、経腸栄養剤を適度に増粘させる点から、本発明のペクチン水溶液の粘度(25℃)は、1mPa・s以上とする。   Further, the aqueous pectin solution of the present invention has a viscosity (25 ° C.) of 30 mPa · s or less, preferably 10 mPa · s or less. If the viscosity of the aqueous pectin solution is too high, it becomes difficult to administer the aqueous pectin solution through a tube having an inner diameter of about 1 to 5 mm used for tube administration. The aqueous solution is suitable for tube administration and can be preferably used particularly by nasogastric tube method. In addition, the viscosity (25 degreeC) of the pectin aqueous solution of this invention shall be 1 mPa * s or more from the point which increases an enteral nutrient moderately.

本発明のペクチン水溶液において、ペクチンの含有量は、ペクチン水溶液の粘度が上述の範囲となるようにペクチンの分子量等に応じて適宜調整することができ、例えば、ペクチンの粘度平均分子量が10000〜35000の場合、1〜5質量%とすればよい。ペクチンの含有量が少なすぎると経腸栄養剤を十分に増粘させることができず、反対に多すぎると経腸栄養剤との反応で強固なゲルが生成されるので、消化吸収の面から好ましくない。   In the pectin aqueous solution of the present invention, the content of pectin can be appropriately adjusted according to the molecular weight of pectin so that the viscosity of the pectin aqueous solution is in the above range. For example, the viscosity average molecular weight of pectin is 10,000 to 35,000. In this case, the content may be 1 to 5% by mass. If the content of pectin is too small, the enteral nutrient cannot be thickened sufficiently. On the other hand, if it is too much, a strong gel is formed by the reaction with the enteral nutrient, so from the aspect of digestion and absorption. It is not preferable.

本発明のペクチン水溶液では、カルシウム濃度が9ppm以下と低いことも特徴としている。従来のエステル化度が10%程度のローメトキシルペクチンは、カルシウムを1000ppm以上含有するため、ローメトキシルペクチンを1質量%水溶液となるように希釈した場合でも、その水溶液のカルシウム濃度は、10ppm以上になる。このような従来のローメトキシルペクチンを水溶液にすると、それを常温で10日間程度保存している間に澱が生じる。そのため、これを経腸栄養剤の増粘剤として使用する者等に品質上の不安を抱かせてしまう。また、澱がチューブに付着するとチューブの閉塞を引き起こし、チューブが詰まる危険性がある。これに対し、本発明ではペクチン水溶液におけるカルシウム濃度を9ppm以下、好ましくは4.5ppm以下とすることにより、ペクチン水溶液の保存中の澱の発生を抑制している。   The aqueous pectin solution of the present invention is also characterized by a low calcium concentration of 9 ppm or less. Since conventional low methoxyl pectin having a degree of esterification of about 10% contains 1000 ppm or more of calcium, even when low methoxyl pectin is diluted to a 1% by mass aqueous solution, the calcium concentration of the aqueous solution is 10 ppm or more. Become. When such a conventional low methoxyl pectin is made into an aqueous solution, starch is produced during storage for about 10 days at room temperature. For this reason, those who use it as a thickener for enteral nutrients are made to worry about quality. In addition, if the starch adheres to the tube, the tube may be blocked and the tube may be clogged. On the other hand, in the present invention, the generation of starch during storage of the aqueous pectin solution is suppressed by setting the calcium concentration in the aqueous pectin solution to 9 ppm or less, preferably 4.5 ppm or less.

また、本発明のペクチン水溶液は、pHが好ましくは2〜8、より好ましくは3.5〜6である。pHが低すぎても高すぎても保存中にペクチンの低分子化が起こり、ペクチンの粘度平均分子量が前述の好ましい範囲を下回るおそれがあるためである。   Moreover, the pH of the aqueous pectin solution of the present invention is preferably 2 to 8, more preferably 3.5 to 6. This is because, when the pH is too low or too high, the pectin may have a low molecular weight during storage, and the viscosity average molecular weight of the pectin may fall below the above-described preferable range.

本発明のペクチン水溶液は、必要により、pH調整剤、ビタミン、ミネラル、増粘多糖類、安定剤等の任意成分を含有することができる。   The aqueous pectin solution of the present invention can contain optional components such as a pH adjuster, vitamins, minerals, thickening polysaccharides, and stabilizers as necessary.

本発明のペクチン水溶液の製造方法としては、例えば、市販のエステル化度5〜15%のローメトキシルペクチンを原料ペクチンとし、それを純水に溶解させることによりペクチン濃度が1〜5質量%のペクチン水溶液を調製し、そのカルシウム濃度を測定する。一般的なペクチンはカルシウム濃度が高く、ペクチン濃度が1〜5質量%のペクチン水溶液を調製した場合のペクチン水溶液のカルシウム濃度は10ppm以上となる。これに対し、本発明では、ペクチン濃度が1〜5質量%のペクチン水溶液のカルシウム濃度が9ppmを超える場合には、原料ペクチンにカルシウム低減処理をすることにより同様にペクチン濃度1〜5質量%に調製したペクチン水溶液中のカルシウム濃度を9ppm以下に低減する。一方、カルシウム濃度が9ppm以下の場合には、その原料ペクチンを、カルシウム低減処理をすることなく本発明で使用できるペクチンとして選択する。   As a method for producing an aqueous pectin solution of the present invention, for example, a commercially available low methoxyl pectin having a degree of esterification of 5 to 15% is used as a raw material pectin, and it is dissolved in pure water so that the pectin concentration is 1 to 5% by mass. An aqueous solution is prepared and its calcium concentration is measured. A general pectin has a high calcium concentration, and when a pectin aqueous solution having a pectin concentration of 1 to 5% by mass is prepared, the calcium concentration of the pectin aqueous solution is 10 ppm or more. In contrast, in the present invention, when the calcium concentration of the pectin aqueous solution having a pectin concentration of 1 to 5% by mass exceeds 9 ppm, the pectin concentration is similarly reduced to 1 to 5% by mass by subjecting the raw material pectin to a calcium reduction treatment. The calcium concentration in the prepared aqueous pectin solution is reduced to 9 ppm or less. On the other hand, when the calcium concentration is 9 ppm or less, the raw material pectin is selected as a pectin that can be used in the present invention without calcium reduction treatment.

カルシウム低減処理を施したペクチン、又はカルシウム低減処理が不要であるとして選択したペクチンを水で希釈し、必要に応じて加熱処理あるいは酵素処理を施すことによりペクチンを低分子化して粘度平均分子量を10000〜35000、好ましくは12000〜27000に調整し、ペクチン水溶液の粘度が1〜30mPa・sとなる本発明のペクチン水溶液を得ることができる。あるいは、ペクチン水溶液が上述の粘度となるようにペクチンを水で希釈した後にカルシウム低減処理を行っても良い。なお、ここで使用する水としては、純水またはイオン交換水が好ましい。   Pectin that has been subjected to calcium reduction treatment, or pectin selected as not requiring calcium reduction treatment is diluted with water and subjected to heat treatment or enzyme treatment as necessary to lower the molecular weight of pectin, resulting in a viscosity average molecular weight of 10,000. The aqueous pectin solution of the present invention having a viscosity of 1 to 30 mPa · s can be obtained by adjusting to ˜35000, preferably 12000 to 27000. Or you may perform a calcium reduction process, after diluting pectin with water so that pectin aqueous solution may become the above-mentioned viscosity. In addition, as water used here, a pure water or ion-exchange water is preferable.

ここで、カルシウム低減処理としては、硝酸含有イソプロパノール溶液等の含水酸性溶媒で洗浄する方法、イオン交換樹脂を用いる方法、限外濾過膜によって濾過する方法などをあげることができる。なかでも、製造工程の煩雑さが少ない点から、カルシウム低減処理としては、イオン交換樹脂を用いる方法が好ましい。   Here, examples of the calcium reduction treatment include a method of washing with a hydrous acidic solvent such as a nitric acid-containing isopropanol solution, a method using an ion exchange resin, and a method of filtering through an ultrafiltration membrane. Especially, the method using an ion exchange resin is preferable as a calcium reduction process from the point with few complexity of a manufacturing process.

また、上述の加熱処理としては、温度100〜145℃、時間2〜100分で加熱加圧処理を行い、ペクチン水溶液を粘度平均分子量10000〜35000に低分子化することが好ましい。この加熱加圧処理は、ペクチン水溶液を容器に充填した後に行ってもよい。   Moreover, as said heat processing, it is preferable to heat-press at a temperature of 100-145 degreeC and time 2-100 minutes, and to make low molecular weight the pectin aqueous solution to the viscosity average molecular weight 10000-35000. This heat and pressure treatment may be performed after the pectin aqueous solution is filled in the container.

また、本発明のペクチン水溶液の製造工程においては、リン酸、酢酸、クエン酸等の有機酸や酢酸塩、クエン酸塩等の有機酸塩、リン酸塩等のpH調整剤の添加によりpHを2〜8に調整することが好ましい。   Further, in the production process of the aqueous pectin solution of the present invention, the pH is adjusted by adding an organic acid such as phosphoric acid, acetic acid and citric acid, an organic acid salt such as acetate and citrate, and a pH adjusting agent such as phosphate. It is preferable to adjust to 2-8.

本発明のペクチン水溶液は、経腸栄養剤を胃内で増粘させる経管投与用増粘剤として有用であり、この他、嚥下困難者の嚥下を容易にするトロミ剤、半固形化剤等としても使用することができる。   The aqueous pectin solution of the present invention is useful as a thickener for tube administration that thickens enteral nutrients in the stomach. Can also be used.

以下、本発明を実施例に基づいて具体的に説明する。
実施例1〜10、比較例1〜9
表1に示すように、製造者、製品名又はロットが異なることにより、エステル化度、分子量、カルシウム含有量が異なる市販の6種類のペクチン(A〜G)を用意した。また、市販の経腸栄養剤増粘用のペクチン液(H)を用意した(比較例9)。
Hereinafter, the present invention will be specifically described based on examples.
Examples 1-10, Comparative Examples 1-9
As shown in Table 1, six types of commercially available pectin (A to G) having different esterification degrees, molecular weights, and calcium contents were prepared by different manufacturers, product names, or lots. In addition, a commercially available pectin solution (H) for thickening enteral nutrients was prepared (Comparative Example 9).

実施例1では、エステル化度が7%のペクチンAを、3質量%となるように純水で溶解し、その100gを耐熱容器に充填密封し、温度110℃、で30分間、加熱加圧処理することによりペクチン水溶液を製造した。   In Example 1, pectin A having a degree of esterification of 7% was dissolved in pure water so as to be 3% by mass, 100 g of which was filled and sealed in a heat-resistant container, and heated and pressurized at a temperature of 110 ° C. for 30 minutes. The pectin aqueous solution was manufactured by processing.

また、表1に示す原料ペクチンA〜Gを使用して表1の濃度のペクチン水溶液を調製し、ペクチン水溶液に対するカルシウム低減処理又はペクチンの低分子化処理を表1に記載のように行い、実施例2〜10、及び比較例1〜8のペクチン水溶液を製造した。   Moreover, the pectin aqueous solution of the density | concentration of Table 1 was prepared using the raw material pectin AG shown in Table 1, and the calcium reduction process or the molecular weight reduction process of pectin with respect to pectin aqueous solution was performed as shown in Table 1, and it implemented. The aqueous pectin solutions of Examples 2 to 10 and Comparative Examples 1 to 8 were produced.

比較例9のペクチン液におけるペクチンの正確な含有量は不明であるが、ペクチン含有量に相当する食物繊維含量がペクチン液100g当たり6gである。   Although the exact content of pectin in the pectin solution of Comparative Example 9 is unknown, the dietary fiber content corresponding to the pectin content is 6 g per 100 g of pectin solution.

評価
各実施例及び比較例で得たペクチン水溶液について、(a)製造したペクチン水溶液のペクチンの粘度平均分子量、(b)製造したペクチン水溶液の粘度、(c)カルシウム濃度、(d)カルシウム・ナトリウム水溶液との反応性、(e)pH、(f)保存後の澱の発生状態、(g)経管投与増粘剤としての使いやすさ、(h)経腸栄養剤との混合粘度、(i)臨床試験、を次のように測定あるいは評価した。結果を表1に示す。
Evaluation About the pectin aqueous solution obtained in each Example and Comparative Example, (a) viscosity average molecular weight of pectin of the produced pectin aqueous solution, (b) viscosity of the produced pectin aqueous solution, (c) calcium concentration, (d) calcium sodium Reactivity with aqueous solution, (e) pH, (f) Starch generation state after storage, (g) Ease of use as a tube administration thickener, (h) Viscosity with enteral nutrients, ( i) Clinical trials were measured or evaluated as follows. The results are shown in Table 1.

(a)ペクチンの粘度平均分子量
極限粘度法により、粘度平均分子量を次のように測定した。
即ち、表1の濃度のペクチン水溶液を0.2mol/L濃度の塩化ナトリウム溶液にて希釈し試料溶液を作成した。具体的には、BL型粘度計(東機産業株式会社製)ローターNo.10、12rpm、25℃の条件で測定した粘度が20mPa・s未満の時は、ペクチン水溶液を40mL、20mL、10mL、5mL、2.5mL正確に量り、それぞれに0.2mol/L濃度の塩化ナトリウム溶液を加えて正確に40mLとした溶液を試料溶液とした。また、BL型粘度計で測定した粘度が20mPa・s以上の時は、ペクチン水溶液を8mL、4mL、2mL、1mL正確に量り、それぞれに0.2mol/L濃度の塩化ナトリウム溶液を加えて正確に40mLとした溶液を試料溶液とした。この試料溶液および0.2mol/L濃度の塩化ナトリウム溶液(ブランク)について、日本薬局方(第十五改正)一般試験法の粘度測定法(第1法毛細管粘度計法)により20.0±0.1℃で比粘度を測定し(式A)、各濃度における還元粘度を算出した(式B)。還元粘度を縦軸に、試料溶液のペクチン濃度(g/100mL)を横軸にとってグラフを描き、各点を結ぶ直線と縦軸との交点から極限粘度を求めた。ここで求められた極限粘度をOwensの式(式C)に代入し、平均分子量を算出した(H. S. Owens, H.
Lotzkar, T. H. Sxhultz, W. D. Maclay J. Am. Chem. Soc. 1946, 68 (8)1628-1632.)。
(a) Viscosity average molecular weight of pectin The viscosity average molecular weight was measured by the intrinsic viscosity method as follows.
That is, a sample solution was prepared by diluting a pectin aqueous solution having a concentration shown in Table 1 with a 0.2 mol / L sodium chloride solution. Specifically, when the viscosity measured under conditions of BL type viscometer (manufactured by Toki Sangyo Co., Ltd.) rotor No. 10, 12 rpm, 25 ° C. is less than 20 mPa · s, 40 mL, 20 mL, 10 mL, 5 mL and 2.5 mL were accurately measured, and a 0.2 mol / L sodium chloride solution was added to each to make exactly 40 mL. When the viscosity measured with a BL-type viscometer is 20 mPa · s or more, accurately measure 8 mL, 4 mL, 2 mL, and 1 mL of pectin aqueous solution, and add 0.2 mol / L sodium chloride solution to each. A solution of 40 mL was used as a sample solution. About this sample solution and 0.2 mol / L sodium chloride solution (blank), 20.0 ± 0 according to the viscosity measurement method (first method capillary viscometer method) of the Japanese Pharmacopoeia (15th revision) general test method The specific viscosity was measured at 1 ° C. (formula A), and the reduced viscosity at each concentration was calculated (formula B). A graph was drawn with the reduced viscosity on the vertical axis and the pectin concentration (g / 100 mL) of the sample solution on the horizontal axis, and the intrinsic viscosity was determined from the intersection of the straight line connecting the points and the vertical axis. The intrinsic viscosity obtained here was substituted into Owens' formula (formula C) to calculate the average molecular weight (HS Owens, H.
Lotzkar, TH Sxhultz, WD Maclay J. Am. Chem. Soc. 1946, 68 (8) 1628-1632.).

Figure 0005505577
Figure 0005505577

(b)ペクチン水溶液の粘度
ペクチン水溶液をBL型粘度計(東機産業株式会社製)で、ローターNo.10、12rpm、液温25℃で測定した。なお、比較例8のペクチン水溶液は、粘度が50mPa・s以上であったため6rpmで測定し、比較例9のペクチン液は0.6rpmで測定した。
(b) Viscosity of Pectin Aqueous Solution A pectin aqueous solution was measured with a BL type viscometer (manufactured by Toki Sangyo Co., Ltd.) at rotor No. 10, 12 rpm, and a liquid temperature of 25 ° C. Since the aqueous pectin solution of Comparative Example 8 had a viscosity of 50 mPa · s or more, it was measured at 6 rpm, and the pectin solution of Comparative Example 9 was measured at 0.6 rpm.

(c)ペクチン水溶液のカルシウム濃度
ICP発光分光分析法により測定した。
(c) Calcium concentration of aqueous pectin solution Measured by ICP emission spectroscopy.

(d)ペクチン水溶液のカルシウム・ナトリウム水溶液との反応性
塩化カルシウム・二水和物)0.019mol/L、クエン酸三ナトリウム・二水和物0.020mol/Lのカルシウム・ナトリウム水溶液を調製した。
ペクチン水溶液100mLとカルシウム・ナトリウム水溶液200mLとの合計300mLを300mLビーカーに計りとり、30秒間撹拌し、ペクチン水溶液とカルシウム・ナトリウム水溶液とを混合してから5分後の粘度をBH型粘度計(東京計器株式会社製)で20rpm、液温25℃で測定した。
(d) Reactivity of pectin aqueous solution with calcium / sodium aqueous solution Calcium chloride / dihydrate) 0.019 mol / L, trisodium citrate dihydrate 0.020 mol / L calcium / sodium aqueous solution was prepared. .
A total of 300 mL of 100 mL of pectin aqueous solution and 200 mL of calcium / sodium aqueous solution is weighed in a 300 mL beaker, stirred for 30 seconds, and mixed with pectin aqueous solution and calcium / sodium aqueous solution. Measured at 20 rpm and a liquid temperature of 25 ° C.

(e)ペクチン水溶液のpH
メトラー・トレド(株)製 セブンイージーS20で測定した。
(e) pH of aqueous pectin solution
Measured with a METTLER TOLEDO Co., Ltd. Seven Easy S20.

(f) 保存後の澱の発生
ペクチン水溶液を製造後、60℃で4週間保存し、澱の発生の有無を目視観察し、次の基準で評価した。
◎:澱は発生していない
○:わずかに澱の発生がみられるが、問題ない程度
×:澱が大量に発生している
(f) Generation of starch after storage After producing an aqueous pectin solution, it was stored at 60 ° C. for 4 weeks, and the presence or absence of starch generation was visually observed and evaluated according to the following criteria.
A: No starch is generated. O: A slight amount of starch is generated, but there is no problem. X: A large amount of starch is generated.

(g) 経管投与増粘剤としての使いやすさ
ペクチン水溶液を50mLシリンジで、太さ8Fr.長さ90cmの栄養チューブ(株式会社JMS製)に注入し、押し出し易さを次の基準で評価した。
◎:非常に注入しやすい
○:抵抗感はあるが、問題なく注入できる
×:固くてシリンジを押し込めず、注入できない
(g) Ease of use as a tube administration thickener Using a 50 mL syringe, a pectin aqueous solution is 8 Fr. The mixture was poured into a 90 cm-long nutrition tube (manufactured by JMS Co., Ltd.), and the ease of extrusion was evaluated according to the following criteria.
◎: Very easy to inject ○: Although there is a sense of resistance, it can be injected without problems ×: The syringe is hard and cannot be injected and cannot be injected

(h)経腸栄養剤との混合試験
500mLビーカーにペクチン水溶液100mLを入れ、そこにナトリウム含量の異なる市販の経腸栄養剤の2種(ジャネフK-4SまたはジャネフK-LEC、キユーピー株式会社製)400mLを加え30秒間撹拌し、ペクチン水溶液と経腸栄養剤とを混合してから5分後の粘度をBH型粘度計(東京計器株式会社製)でローターNo.2、20rpm、液温25℃で測定した。なお、比較例9のペクチン液をジャネフK-4Sと混合した場合には、BH型粘度計のローターNo.3を使用し、ジャネフK-LECと混合した場合には、BH型粘度計のローターNo.4を使用した。
(h) Mixing test with enteral nutrients 100 mL of pectin aqueous solution was put into a 500 mL beaker, and two types of commercially available enteral nutrients with different sodium contents (Janev K-4S or Janef K-LEC, manufactured by QP Corporation) ) Add 400 mL and stir for 30 seconds. After mixing the aqueous pectin solution and enteral nutrient, the viscosity after 5 minutes is measured using a BH viscometer (manufactured by Tokyo Keiki Co., Ltd.), rotor No. 2, 20 rpm, liquid temperature 25 Measured at ° C. When the pectin solution of Comparative Example 9 was mixed with Janef K-4S, the rotor No. 3 of the BH type viscometer was used. When mixed with Janef K-LEC, the rotor of the BH type viscometer was used. No. 4 was used.

ここで、使用した経腸栄養剤のカルシウム含量とナトリウム含量は次の通りである。
ジャネフK-4S
Ca含量:60mg/100mL
Na含量:180mg/100mL
ジャネフK-LEC
Ca含量:60mg/100mL
Na含量:80mg/100mL
Here, the calcium content and sodium content of the enteral nutrient used are as follows.
Janef K-4S
Ca content: 60 mg / 100 mL
Na content: 180mg / 100mL
Janef K-LEC
Ca content: 60 mg / 100 mL
Na content: 80mg / 100mL

(i)臨床試験
経腸栄養剤(カルシウム濃度60mg/100mL、ナトリウム濃度180mg/100mL)の投与を受けており、下痢や嘔吐の症状がある患者に対し、経腸栄養剤の投与時に、その経腸栄養剤400mLにつき本発明のペクチン水溶液約100mLを3日間投与し、症状の改善の有無を調べ、次の基準で評価した。
○:嘔吐や下痢の症状が改善された。
×:嘔吐や下痢の症状が改善されない
(i) Clinical study Enteral nutrient (calcium concentration 60 mg / 100 mL, sodium concentration 180 mg / 100 mL) has been administered to patients with symptoms of diarrhea and vomiting. About 100 mL of the pectin aqueous solution of the present invention was administered for 3 days per 400 mL of enteric nutrient, and the presence or absence of symptom improvement was examined and evaluated according to the following criteria.
○: Symptoms of vomiting and diarrhea improved.
×: Symptoms of vomiting and diarrhea are not improved

Figure 0005505577
Figure 0005505577

表1から、本発明の各実施例のペクチン水溶液は、ペクチンのエステル化度が5〜15%の範囲にあり、かつ、ペクチンの粘度平均分子量が10000〜35000の範囲にあるので、カルシウム・ナトリウム水溶液を十分に増粘させることがわかる。なお、これらの実施例では、加熱加圧処理により(実施例1〜8、10)、あるいは酵素処理により(実施例9)、分子量の低分子化が行われている。
さらに、実施例1のペクチン水溶液は、ナトリウムが多い経腸栄養剤(K-4S)と少ない経腸栄養剤(K-LEC)のどちらでも増粘させることができたから、本発明の各実施例は、ナトリウム含量の多い少ないに関わらず経腸栄養剤を増粘できることがわかる。
From Table 1, since the pectin aqueous solution of each Example of this invention has the esterification degree of pectin in the range of 5 to 15%, and the viscosity average molecular weight of pectin is in the range of 10,000 to 35000, calcium sodium It can be seen that the aqueous solution is sufficiently thickened. In these examples, the molecular weight is reduced by heat and pressure treatment (Examples 1 to 8 and 10) or by enzyme treatment (Example 9).
Furthermore, since the aqueous pectin solution of Example 1 was able to thicken both enteral nutrient (K-4S) rich in sodium and enteral nutrient (K-LEC) low in sodium, each example of the present invention It can be seen that enteral nutrients can be thickened regardless of whether the sodium content is high or low.

また、これらの実施例は、原料となるペクチンとしてカルシウム含量が低いものを選択することによりペクチン水溶液にカルシウム低減処理をせず、ペクチン水溶液中のカルシウム濃度を9ppm以下にしたものや(実施例1〜7、9)、イオン交換樹脂の使用によりカルシウム濃度を低減させてペクチン水溶液中のカルシウム濃度を9ppm以下にしたもの(実施例8、10)であり、いずれも保存後に問題となるほどの量の澱は発生していない。特に、ペクチン水溶液中のカルシウム濃度が4.5ppm以下であると(実施例1〜5、7〜9)、澱が発生しないことがわかる。   Further, in these examples, the pectin used as a raw material is selected to have a low calcium content, so that the calcium concentration in the aqueous pectin solution is not reduced to 9 ppm or less (Example 1 -7, 9), wherein the calcium concentration in the aqueous pectin solution was reduced to 9 ppm or less by using an ion exchange resin (Examples 8 and 10). Starch is not generated. In particular, when the calcium concentration in the aqueous pectin solution is 4.5 ppm or less (Examples 1 to 5 and 7 to 9), it can be seen that no starch is generated.

これに対し、粘度平均分子量が35000を超える比較例1ではカルシウム・ナトリウム水溶液との反応で強固なゲルが形成され、その粘度は測定不能であった。したがって、比較例1のペクチン水溶液を胃内で経腸栄養剤と混合すると、胃内に強固なゲルが形成され、消化吸収が十分に行われず、経腸栄養剤の栄養を必要量吸収できない弊害が生じると考えられる。   On the other hand, in Comparative Example 1 having a viscosity average molecular weight exceeding 35,000, a strong gel was formed by reaction with the calcium / sodium aqueous solution, and its viscosity was not measurable. Therefore, when the aqueous pectin solution of Comparative Example 1 is mixed with an enteral nutrient in the stomach, a strong gel is formed in the stomach, digestion and absorption are not sufficiently performed, and the nutrition of the enteral nutrient cannot be absorbed in a necessary amount. Is considered to occur.

一方、比較例5のペクチン水溶液は、エステル化度が15%を超えることによりカルシウム・ナトリウム水溶液と反応性が低く、ナトリウム含有量が多い経腸栄養剤(K-4S)だけでなく、ナトリウム含有量が少ない経腸栄養剤(K-LEC)も十分に増粘することができなかった。   On the other hand, the aqueous pectin solution of Comparative Example 5 has low reactivity with calcium / sodium aqueous solution due to the degree of esterification exceeding 15%, and contains not only enteral nutrient (K-4S) with high sodium content but also sodium content. A small amount of enteral nutrient (K-LEC) could not be thickened sufficiently.

比較例6、7、8のペクチン水溶液でもエステル化度が15%を超えるペクチンを原料とした。このうち、比較例6では、低分子化処理後の粘度平均分子量が35000を超えていたが、エステル化度が高いことにより、カルシウム・ナトリウム水溶液を十分に増粘させることができなかった。比較例7では加熱処理による低分子化を行わなかったので、カルシウム・ナトリウム水溶液を十分に増粘させることはできたものの、ペクチン水溶液自体の粘度が30mPa・sを超えることにより、それを栄養チューブに注入することができなかった。また、比較例8ではペクチン水溶液中のペクチン含量を高めることによりカルシウム・ナトリウム水溶液との反応性を高めようとしたものであるが、ペクチン水溶液自体の粘度が30mPa・sを超え、それを栄養チューブに注入することができなかった。   Even in the aqueous pectin solutions of Comparative Examples 6, 7, and 8, pectin having an esterification degree exceeding 15% was used as a raw material. Among these, in Comparative Example 6, the viscosity average molecular weight after the molecular weight reduction treatment exceeded 35,000, but due to the high degree of esterification, the calcium / sodium aqueous solution could not be sufficiently thickened. In Comparative Example 7, since the molecular weight was not reduced by heat treatment, the calcium / sodium aqueous solution could be sufficiently thickened. However, when the viscosity of the pectin aqueous solution itself exceeded 30 mPa · s, it was applied to the feeding tube. Could not be injected. In Comparative Example 8, the pectin content in the aqueous pectin solution was increased to increase the reactivity with the calcium / sodium aqueous solution, but the viscosity of the aqueous pectin solution itself exceeded 30 mPa · s, and this was applied to the feeding tube. Could not be injected.

一方、比較例2では、実施例1と同様のペクチンを原料としたが、その含有量を高めたことによりペクチン水溶液自体の粘度が30mPa・sを超え、それを栄養チューブに注入することができなかった。   On the other hand, in Comparative Example 2, the same pectin as in Example 1 was used as a raw material, but by increasing its content, the viscosity of the pectin aqueous solution itself exceeded 30 mPa · s, which could be injected into the feeding tube. There wasn't.

また、水溶液中のカルシウム濃度が9ppmを超える比較例2〜4、6〜9では、いずれも保存後に澱が発生した。このうち、比較例2、3は、実施例1と同様のペクチンを原料としたものであるが、比較例2では原料ペクチンの含有量を高めたことによりペクチン水溶液中のカルシウム濃度が高まり、また、比較例3では希釈水に水道水をしたため、水道水中に含まれるカルシウムによりペクチン水溶液中のカルシウム濃度が高まり、それぞれ澱が発生したものと考えられる。比較例9の市販の経腸栄養剤増粘用ペクチン液のカルシウム濃度が、実施例1〜10よりも10倍以上高いことがわかる。   In Comparative Examples 2 to 4 and 6 to 9 where the calcium concentration in the aqueous solution exceeded 9 ppm, starch was generated after storage. Of these, Comparative Examples 2 and 3 were made from the same pectin as in Example 1, but in Comparative Example 2, the calcium concentration in the pectin aqueous solution increased due to the increased content of the raw pectin, In Comparative Example 3, since the tap water was used as the dilution water, the calcium concentration in the aqueous pectin solution was increased by the calcium contained in the tap water, and it was considered that starch was generated respectively. It turns out that the calcium concentration of the commercially available enteral nutrient thickening pectin liquid of the comparative example 9 is 10 times or more higher than Examples 1-10.

本発明のペクチン水溶液は、経腸栄養剤の増粘剤、嚥下補助食品としてのトロミ剤、半固形化剤として使用することができる。
The aqueous pectin solution of the present invention can be used as a thickener for enteral nutrients, a trotomy agent as a swallowing supplement, or a semi-solidifying agent.

Claims (11)

エステル化度5〜15%、粘度平均分子量が10000〜35000のペクチンを含有するペクチン水溶液であって、ペクチン水溶液のカルシウム濃度が9ppm以下、ペクチン水溶液の粘度(25℃)が1〜30mPa・sであり、前記ペクチン水溶液100mLと、塩化カルシウム0.019mol/L、クエン酸ナトリウム0.020mol/Lのカルシウム・ナトリウム水溶液200mLとの混合液の粘度(25℃)が700〜10000mPa・sとなるペクチン水溶液。   A pectin aqueous solution containing pectin having an esterification degree of 5 to 15% and a viscosity average molecular weight of 10,000 to 35,000, wherein the calcium concentration of the pectin aqueous solution is 9 ppm or less, and the viscosity (25 ° C.) of the pectin aqueous solution is 1 to 30 mPa · s. A pectin aqueous solution in which the viscosity (25 ° C.) of a mixture of 100 mL of the aqueous pectin solution and 200 mL of an aqueous calcium / sodium solution of 0.019 mol / L of calcium chloride and 0.020 mol / L of sodium citrate is 700 to 10,000 mPa · s. . ペクチンの含有量が1〜5質量%である請求項1記載のペクチン水溶液。   The pectin aqueous solution according to claim 1, wherein the content of pectin is 1 to 5% by mass. pHが2〜8である請求項1又は2記載のペクチン水溶液。   The aqueous pectin solution according to claim 1 or 2, having a pH of 2 to 8. カルシウム低減処理がなされている請求項1〜3のいずれかに記載のペクチン水溶液。   The pectin aqueous solution according to any one of claims 1 to 3, wherein a calcium reduction treatment is performed. 請求項1〜4のいずれかに記載のペクチン水溶液からなる経管投与用増粘剤。   The thickener for tube administration which consists of the pectin aqueous solution in any one of Claims 1-4. 胃内で経腸栄養剤を増粘させるために使用する請求項5記載の経管投与用増粘剤。   The thickener for tube administration according to claim 5, which is used for thickening an enteral nutrient in the stomach. エステル化度5〜15%のペクチンであって、該ペクチンを水で希釈してペクチン含有量1〜5質量%のペクチン水溶液を調製した場合に、そのペクチン水溶液のカルシウム濃度が9ppm以下となるペクチンを原料ペクチンとしてこれを水で希釈し、ペクチン水溶液の粘度(25℃)を1〜30mPa・sに調整する請求項1〜4のいずれかに記載のペクチン水溶液の製造方法。   Pectin having a degree of esterification of 5 to 15%, and when the pectin is diluted with water to prepare a pectin aqueous solution having a pectin content of 1 to 5% by mass, the calcium concentration of the pectin aqueous solution is 9 ppm or less. The method for producing an aqueous pectin solution according to any one of claims 1 to 4, wherein the pectin solution is diluted with water to adjust the viscosity (25 ° C) of the aqueous pectin solution to 1 to 30 mPa · s. エステル化度5〜15%のペクチンであって、該ペクチンを水で希釈してペクチン含有量1〜5質量%のペクチン水溶液を調製した場合に、そのペクチン水溶液のカルシウム濃度が9ppmを超えるとき、ペクチンにカルシウム低減処理を行い、同様に調製したペクチン水溶液のカルシウム濃度が9ppm以下となるものを原料ペクチンとする請求項7記載のペクチン水溶液の製造方法。   When the pectin has an esterification degree of 5 to 15% and the pectin is diluted with water to prepare a pectin aqueous solution having a pectin content of 1 to 5% by mass, when the calcium concentration of the pectin aqueous solution exceeds 9 ppm, The method for producing an aqueous pectin solution according to claim 7, wherein the pectin is subjected to a calcium reduction treatment, and the pectin aqueous solution prepared in the same manner has a calcium concentration of 9 ppm or less as a raw material pectin. 粘度平均分子量10000〜35000となるように低分子化処理を施す請求項7又は8記載のペクチン水溶液の製造方法。   The method for producing an aqueous pectin solution according to claim 7 or 8, wherein the molecular weight reduction treatment is performed so that the viscosity average molecular weight is 10,000 to 35,000. 低分子化処理として、温度100〜145℃、加熱加圧処理を2〜100分行う請求項9記載のペクチン水溶液の製造方法。   The method for producing a pectin aqueous solution according to claim 9, wherein the molecular weight reduction treatment is performed at a temperature of 100 to 145 ° C. for 2 to 100 minutes. pH2〜8に調整する請求項7〜10のいずれかに記載のペクチン水溶液の製造方法。
The manufacturing method of the pectin aqueous solution in any one of Claims 7-10 adjusted to pH 2-8.
JP2013553705A 2012-07-09 2013-07-09 Pectin aqueous solution Active JP5505577B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013553705A JP5505577B1 (en) 2012-07-09 2013-07-09 Pectin aqueous solution

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2012153873 2012-07-09
JP2012153873 2012-07-09
PCT/JP2013/068714 WO2014010577A1 (en) 2012-07-09 2013-07-09 Aqueous pectin solution
JP2013553705A JP5505577B1 (en) 2012-07-09 2013-07-09 Pectin aqueous solution

Publications (2)

Publication Number Publication Date
JP5505577B1 true JP5505577B1 (en) 2014-05-28
JPWO2014010577A1 JPWO2014010577A1 (en) 2016-06-23

Family

ID=49916029

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013553705A Active JP5505577B1 (en) 2012-07-09 2013-07-09 Pectin aqueous solution

Country Status (5)

Country Link
JP (1) JP5505577B1 (en)
KR (1) KR102100103B1 (en)
CN (1) CN103974723B (en)
HK (1) HK1200725A1 (en)
WO (1) WO2014010577A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105664170A (en) * 2016-01-23 2016-06-15 杭州吉为医疗科技有限公司 Amidated low-ester pectin composition and method for preparing same
US10363267B2 (en) * 2016-06-17 2019-07-30 Otsuka Pharmaceutical Factory, Inc. Diarrhea-preventing nutritional composition
CN107518411A (en) * 2017-01-13 2017-12-29 江苏西宏生物医药有限公司 A kind of anti-diarrhea enteral nutrition composition
CN107616984A (en) * 2017-01-13 2018-01-23 江苏西宏生物医药有限公司 A kind of anti-diarrhea enteral nutrition composition
CN107594483A (en) * 2017-01-13 2018-01-19 江苏西宏生物医药有限公司 A kind of pectin solution of stabilization
CN107616983A (en) * 2017-01-13 2018-01-23 江苏西宏生物医药有限公司 A kind of anti-diarrhea enteral nutrition composition
CN107468702A (en) * 2017-09-18 2017-12-15 浙江大学 Pectin solution for treating antibiotic-associated diarrhea and preparation method thereof
CN109007859A (en) * 2018-10-10 2018-12-18 纽湃腾(北京)医药科技有限公司 A kind of stable carbohydrate composition aqueous solution and preparation method and application
CN111166717B (en) * 2019-07-17 2022-01-04 江苏西宏生物医药有限公司 Thermostable enteral nutrient solution
CN110558564A (en) * 2019-09-05 2019-12-13 浙江大学 Gastrointestinal nutrition digestion and absorption regulator
CN111493326A (en) * 2020-04-28 2020-08-07 成都尚医信息科技有限公司 Enteral nutrition food and preparation method and application thereof

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000504772A (en) * 1996-02-15 2000-04-18 ハーキュリーズ・インコーポレイテッド Pectin fiber
JP2002509946A (en) * 1998-01-20 2002-04-02 ハーキュリーズ・インコーポレーテッド Pectin for use in a pasty substance, method for producing the pectin, pasty substance containing pectin, and use thereof
JP2004503613A (en) * 2000-06-09 2004-02-05 シーピー・ケルコ・エイピーエス Low methoxyl pectin, method for producing the same, and stabilized aqueous system comprising the same
JP2006248981A (en) * 2005-03-10 2006-09-21 En Otsuka Pharmaceutical Co Ltd Gelatinizer for nutritive preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6187334B1 (en) 1998-09-09 2001-02-13 Kewpie Kabushiki Kaisha Foods for preventing vomiting
JP3140426B2 (en) 1999-01-28 2001-03-05 キユーピー株式会社 Anti-dumping food
CN100497397C (en) * 2003-07-07 2009-06-10 Kmc卡特费尔美尔中心有限公司 Method for preparing fibre-containing pectin and products and uses hereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000504772A (en) * 1996-02-15 2000-04-18 ハーキュリーズ・インコーポレイテッド Pectin fiber
JP2002509946A (en) * 1998-01-20 2002-04-02 ハーキュリーズ・インコーポレーテッド Pectin for use in a pasty substance, method for producing the pectin, pasty substance containing pectin, and use thereof
JP2004503613A (en) * 2000-06-09 2004-02-05 シーピー・ケルコ・エイピーエス Low methoxyl pectin, method for producing the same, and stabilized aqueous system comprising the same
JP2006248981A (en) * 2005-03-10 2006-09-21 En Otsuka Pharmaceutical Co Ltd Gelatinizer for nutritive preparation

Also Published As

Publication number Publication date
JPWO2014010577A1 (en) 2016-06-23
KR102100103B1 (en) 2020-04-13
CN103974723B (en) 2015-11-25
KR20150028239A (en) 2015-03-13
CN103974723A (en) 2014-08-06
HK1200725A1 (en) 2015-08-14
WO2014010577A1 (en) 2014-01-16

Similar Documents

Publication Publication Date Title
JP5505577B1 (en) Pectin aqueous solution
AU2005292777B2 (en) Enteral nutrient
JP4972308B2 (en) Gelling nutrient and method for producing the same
CN101455631B (en) Meglumine cyclic adenosine injection and preparation technique thereof
CN112088898B (en) Composition containing oxidation-reduction potential water and preparation method thereof
JP6134156B2 (en) Antidiarrheal composition
CN103989630A (en) Moxifloxacin hydrochloride sodium chloride injection and preparation method thereof
CN103735540A (en) Calcium gluconate aqueous solution with high calcium content and preparation method thereof
SE510587C2 (en) Concentrate for dialysis solution and its use
CN106963729A (en) It is a kind of to be used to prevent pharmaceutical preparation of operative hemorrhage and preparation method thereof
ES2908336T3 (en) Suspension comprising aluminum hydroxide and magnesium hydroxide and preparation process thereof
JPH02304026A (en) Liquid for peritoneal lavage
CN106727618B (en) Compound sulfamethoxazole oral suspension and preparation method thereof
CN105476954B (en) A kind of lomefloxacin hydrochloride injection and preparation method
CN111166717B (en) Thermostable enteral nutrient solution
CN108853476A (en) A kind of iron protein succinylate oral solution and preparation method thereof
CN114452250A (en) Procaterol hydrochloride oral liquid and preparation method thereof
TW201639474A (en) Jelling agent composition and food
WO2019227746A1 (en) Chitosan oral solution and preparation method therefor
JP5597490B2 (en) Sugar-containing iron oxide preparation for injection
CN110200905A (en) A kind of ambroxol hydrochloride composition and its injection and application
CN113116921B (en) Sodium bicarbonate injection and preparation method thereof
CN110522730B (en) Amoxicillin soluble powder and preparation method thereof
EP3763358A1 (en) Suspending vehicle formulation
CN107854485A (en) The medical composition and its use of the various trace elements of injection

Legal Events

Date Code Title Description
A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20140107

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20131125

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20140210

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140218

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140303

R150 Certificate of patent or registration of utility model

Ref document number: 5505577

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250